Amanta Healthcare Ltd (AMANTA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544502 | NSE: AMANTA | Pharmaceuticals & Drugs | Small Cap

Amanta Healthcare Share Price

101.60 0.35 0.35%
as on 05-Dec'25 12:16

Amanta Healthcare Ltd (AMANTA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544502 | NSE: AMANTA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Amanta Healthcare

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Amanta Healthcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
37.44
Market Cap:
393.2 Cr.
52-wk low:
100
52-wk high:
154.9

Is Amanta Healthcare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Amanta Healthcare: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amanta Healthcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.6%12.7%10.3%8.4%8.3%8.9%40%13.4%14.2%15.2%-
Value Creation
Index
-0.2-0.1-0.3-0.4-0.4-0.41.90.00.00.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 203211192185184171225259280275275
Sales YoY Gr.-4.2%-9.3%-3.5%-0.3%-7.1%31.6%14.9%8.2%-2%-
Adj EPS 3.46.33.9-7.1-7.5-8.22.1-1.21.53.62.7
YoY Gr.-88.1%-38.6%-282.5%NANANA-156.6%NA143%-
BVPS (₹) 4046.32517.910.92.724.223.424.733.454.3
Adj Net
Profit
12.423.210.3-19-20-22.15.7-3.2410.410
Cash Flow from Ops. 39.640.225.232.237.933.463.542.658.146.6-
Debt/CF from Ops. 2.42.210.17.76.173.55.13.54.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.4%8.3%6.8%-2%
Adj EPS 0.8%NA19.5%143%
BVPS-2%25.2%11.3%35.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
6.911.47.3-33.1-52-121.415.7-5.16.212.86.2
Op. Profit
Mgn %
20.424.424.222.120.322.423.819.820.721.821
Net Profit
Mgn %
6.1115.4-10.3-10.9-12.92.5-1.31.43.83.8
Debt to
Equity
0.50.43.85.27.932.33.43.43.120.6
Working Cap
Days
18019423826927729621517916218177
Cash Conv.
Cycle
6559911141331601201039711139

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Amanta Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 2.7 -
TTM Sales (₹ Cr.) 275 -
BVPS (₹.) 54.3 -
Reserves (₹ Cr.) 172 -
P/BV 1.87 -
PE 37.44 -
From the Market
52 Week Low / High (₹) 100.00 / 154.85
All Time Low / High (₹) 100.00 / 154.85
Market Cap (₹ Cr.) 393
Equity (₹ Cr.) 38.8
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Amanta Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Amanta Healthcare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Amanta Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales203211192185184171225259280275
Operating Expenses 161160145144147133172208223215
Manufacturing Costs21202121231973838483
Material Costs85826867645040617057
Employee Cost 28283031333428323336
Other Costs 28312525263031323638
Operating Profit 41514641373854515760
Operating Profit Margin (%) 20.4%24.3%24.2%22.1%20.3%22.4%23.8%19.6%20.5%21.7%
Other Income 2122211511
Interest 14122041384044353428
Depreciation 14151617161717182018
Exceptional Items 0-0000069000
Profit Before Tax 152512-14-15-18623515
Tax 3214448524
Profit After Tax 132311-19-19-2254-2411
PAT Margin (%) 6.2%11.0%5.9%-10.1%-10.2%-12.7%23.9%-0.8%1.3%3.8%
Adjusted EPS (₹)3.46.34.3-7.0-7.0-8.120.1-0.81.43.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 192215674829765636696
Share Capital 82822727272727272729
Reserves 11013440212-2038363968
Minority Interest0000000000
Debt8676243238227235218211192173
Long Term Debt4232200196192158176176149132
Short Term Debt44434342347742364341
Trade Payables32352922172539362530
Others Liabilities 5864679511512558647288
Total Liabilities 369390406403388392379374355389

Fixed Assets

Gross Block347375396383395399259274279286
Accumulated Depreciation10111312913615215718365168
Net Fixed Assets 246262267247244242241238228217
CWIP 0120000007
Investments 0000023348
Inventories30293438395771695973
Trade Receivables52615452525145544850
Cash Equivalents 657136910443
Others Assets 353242524631971231
Total Assets 369390406403388392379374355389

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 40402532383364435847
PBT 152512-14-15-18623515
Adjustment 282736565459-7545447
Changes in Working Capital -0-7-17-3-1-139-75-11
Tax Paid -3-3-2-7-05-0-6-6-4
Cash Flow From Investing Activity -36-21-175-5-11-17-5-7-10-24
Capex -37-23-15-5-11-12-3-6-12-21
Net Investments 000000-3-01-4
Others 12-160-0-0-50000
Cash Flow From Financing Activity -3-20152-21-35-17-52-42-46-23
Net Proceeds from Shares 10000000020
Net Proceeds from Borrowing 0000000000
Interest Paid -15-12-12-15-19-21-41-29-26-25
Dividend Paid 0000000000
Others 11-7164-6-164-11-13-20-18
Net Cash Flow 0-026-8-06-61-1

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.3314.599.57-32.75-48.98-120.09149.18-3.35.6312.91
ROCE (%)10.6312.6910.338.448.278.9139.9913.4314.1915.16
Asset Turnover Ratio0.610.590.490.460.470.440.580.690.770.74
PAT to CFO Conversion(x)3.081.742.27N/AN/AN/A1.19N/A14.54.27
Working Capital Days
Receivable Days799210810510311178696665
Inventory Days5748597177103104998488
Payable Days132150171140112157291223159176

Amanta Healthcare Ltd Stock News

Amanta Healthcare Ltd FAQs

The current trading price of Amanta Healthcare on 05-Dec-2025 12:16 is ₹101.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Amanta Healthcare stood at ₹393.1.
The latest P/E ratio of Amanta Healthcare as of 04-Dec-2025 is 37.44.
The latest P/B ratio of Amanta Healthcare as of 04-Dec-2025 is 1.87.
The 52-week high of Amanta Healthcare is ₹154.8 and the 52-week low is ₹100.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amanta Healthcare is ₹274.7 ( Cr.) .

About Amanta Healthcare Ltd

Marck Biosciences Limited was originally incorporated as Marck Parenterals (India) Limited on December 1994. Subsequently, the name of the company was changed to Marck Biosciences Limited on November 2, 2005. The company’s registered office is located at 5th Floor, Heritage, Nr. Gujarat Vidhyapith, Off. Ashram Road,Ahmedabad – 380 014, Gujarat, India. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of Fluid Therapy, Injections, Eye Care and Respiratory Care. Its non therapeutic product group comprises of Medical Devices. Medical devices would predominantly be of products such as, Lens cleaning solutions, Eye & wound Irrigation, Eye wash Solution and First aid Solution, for which the company has obtained ‘CE’ mark.

Business Profile:

The company is a sterile liquid pharmaceutical company headquartered at Ahmedabad, Gujarat, India. Its scope of activities includes formulation and development, manufacturing and marketing in India and approximately 77 countries across 6 continents. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of fluid therapy, injections, eye care and respiratory care. The non therapeutic product group comprises of medical devices. medical devices would predominantly be of products such as, lens cleaning solutions, eye and wound irrigation, eye wash solution and first aid Solution, for which the company has obtained ‘CE’ mark. Its manufacturing facilities comprises of five Aseptic Blow Fill Seal (ABFS) manufacturing lines and one Aspectic Conventional Plastic Bottle Filling line. It is one of the versatile manufacturer in BFS space, wherein it offer different closure systems, such as nipple head, twist-off, leur-lock & screw types and container fill-volume ranging from 2ml to 1000 ml.

Product Segment:

  • Fluid Therapy Products
  • Formulations
  • Medical Devices

Promoter Group Companies :

  • Milcent Appliances Private Limited (MAPL)
  • American Mannequin INC

Group entities:

  • Marck Remedies Limited (MRL)
  • Mangneto Induction Pvt Limited
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×